Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Filings indexed 2,023 across all filing types
Latest filing 2020-06-26 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
200626 - UCB Disposals of own shares.pdf
Transaction in Own Shares Classification · 99% confidence The document is explicitly titled "Disposals of own shares" and details transactions where the company disposed of UCB shares OTC in view of delivering them to personnel who exercised stock options under various Long Term Incentive (LTI) Plans. This activity directly relates to the company managing its own equity, specifically through share repurchase or issuance activities related to employee compensation. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K).
2020-06-26 English
200626 - Aliénation d'actions propres.pdf
Remuneration Information Classification · 99% confidence The document title is "Aliénation d'actions propres" (Alienation of own shares) and the content details transactions where UCB SA 'aliéné des actions UCB hors bourse (OTC)' (sold UCB shares over-the-counter) following the exercise of options by personnel, listing specific dates, quantities, and prices. This directly corresponds to the definition of a company reporting transactions involving its own shares, which aligns with the 'Transaction in Own Shares' category (POS). It is not a general insider trading report (DIRS) as it relates to employee compensation plans, nor is it a general financing update (CAP).
2020-06-26 French
200626 - Vervreemding van eigen aandelen.pdf
Transaction in Own Shares Classification · 99% confidence The document title is "Vervreemding van eigen aandelen" (Disposal of own shares) and the text details transactions where UCB shares were delivered to employees as part of long-term incentive plans (stock options). This directly relates to the company buying back or issuing its own shares, specifically in the context of employee share schemes. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). The document is a formal announcement ('gereglementeerde informatie') detailing these transactions.
2020-06-26 Dutch
200619 - UCB Acquisitions and disposals of own shares.pdf
Transaction in Own Shares Classification · 100% confidence The document is a regulatory disclosure from UCB SA/NV dated June 19, 2020, detailing 'Acquisitions and disposals of own shares' under its Share Repurchase Program 2020. It explicitly lists the number of shares repurchased (acquisitions) and shares disposed of (related to stock option exercises) during specific periods in June 2020. This content directly corresponds to the definition of a report concerning the company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category.
2020-06-19 English
200619 - Rachat et Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled 'Rachat et Aliénation d'actions propres' (Share Buyback and Disposal) and details transactions where UCB SA repurchased its own shares ('Rachat d'actions propres') and disposed of shares ('Aliénation d'actions propres') related to employee stock option plans. This activity directly corresponds to the definition of a company reporting transactions involving its own shares. Reviewing the filing types: - 10-K/IR: These are comprehensive financial reports, which this is not. - ER/MRQ: These are earnings announcements, which this is not. - DIRS: This is for director's dealing (insider trades), not general company share transactions. - SHA: This is for general share issue/capital change, but POS is more specific for transactions in own shares. - POS (Transaction in Own Shares): This category perfectly matches the content, which details the buyback (rachat) and disposal (aliénation) of the company's own stock. The document is a detailed report of these transactions, not merely an announcement that a report is available (RPA/RNS). Therefore, the classification is POS.
2020-06-19 English
200619 - Verwerving en vervreemding van eigen aandelen.pdf
Transaction in Own Shares Classification · 100% confidence The document text is titled "Verwerving en vervreemding van eigen aandelen" (Acquisition and disposal of own shares) and details transactions where UCB NV bought back its own shares ('Verwerving van eigen aandelen') and disposed of shares through employee incentive plans ('Vervreemding van eigen aandelen') between June 11, 2020, and June 16, 2020. This activity specifically relates to the company buying back or issuing its own shares, which directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS.
2020-06-19 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.